- Home
- YGMZ vs JSPR Comparison
YGMZ vs JSPR Comparison
Compare YGMZ & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YGMZ
- JSPR
- Stock Information
- Founded
- YGMZ 2002
- JSPR 2018
- Country
- YGMZ China
- JSPR United States
- Employees
- YGMZ 195
- JSPR N/A
- Industry
- YGMZ Transportation Services
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- YGMZ Consumer Discretionary
- JSPR Health Care
- Exchange
- YGMZ Nasdaq
- JSPR Nasdaq
- Market Cap
- YGMZ 101.2M
- JSPR 85.8M
- IPO Year
- YGMZ 2020
- JSPR N/A
- Fundamental
- Price
- YGMZ $1.35
- JSPR $4.52
- Analyst Decision
- YGMZ
- JSPR Strong Buy
- Analyst Count
- YGMZ 0
- JSPR 10
- Target Price
- YGMZ N/A
- JSPR $62.50
- AVG Volume (30 Days)
- YGMZ 242.6K
- JSPR 155.7K
- Earning Date
- YGMZ 01-01-0001
- JSPR 05-20-2025
- Dividend Yield
- YGMZ N/A
- JSPR N/A
- EPS Growth
- YGMZ N/A
- JSPR N/A
- EPS
- YGMZ N/A
- JSPR N/A
- Revenue
- YGMZ $55,805,416.00
- JSPR N/A
- Revenue This Year
- YGMZ N/A
- JSPR N/A
- Revenue Next Year
- YGMZ N/A
- JSPR N/A
- P/E Ratio
- YGMZ N/A
- JSPR N/A
- Revenue Growth
- YGMZ N/A
- JSPR N/A
- 52 Week Low
- YGMZ $0.64
- JSPR $3.13
- 52 Week High
- YGMZ $4.35
- JSPR $26.84
- Technical
- Relative Strength Index (RSI)
- YGMZ 67.80
- JSPR 46.13
- Support Level
- YGMZ $1.20
- JSPR $4.27
- Resistance Level
- YGMZ $1.38
- JSPR $5.67
- Average True Range (ATR)
- YGMZ 0.13
- JSPR 0.43
- MACD
- YGMZ 0.01
- JSPR -0.01
- Stochastic Oscillator
- YGMZ 93.62
- JSPR 22.56
About YGMZ MingZhu Logistics Holdings Limited
MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.